The significance of telomerase activation and cellular immortalization in human cancer

Mutagenesis

Volumn 17, Issue 6, 2002, Pages 539-550

  Newbold, Robert F ^a  

^a BRUNEL UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ARF PROTEIN; PROTEIN P16; PROTEIN P21; PROTEIN P53; RNA DIRECTED DNA POLYMERASE; TELOMERASE; TELOMERASE INHIBITOR; ANTISENSE OLIGODEOXYNUCLEOTIDE; DNA BINDING PROTEIN; ENZYME INHIBITOR;

ANIMAL CELL; APOPTOSIS; CANCER CELL; CANCER PREVENTION; CARCINOGENESIS; CELL AGING; CELL CULTURE; CELL DEATH; CELL IMMORTALIZATION; CELL PROLIFERATION; CELL SELECTION; CELL TRANSFORMATION; CLONE; DRUG TARGETING; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; ENZYME REPRESSION; GENE EXPRESSION; GENE INACTIVATION; GENE INDUCTION; GENE REPLICATION; GENETIC CODE; GENETIC TRANSCRIPTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; INHIBITION KINETICS; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT TRANSFORMATION; MAMMAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; RODENT; TELOMERE; TISSUE REGENERATION; TRANSCRIPTION REGULATION; TUMOR CELL; ANIMAL; BIOLOGICAL MODEL; DRUG ANTAGONISM; ENZYMOLOGY; GENETICS; METABOLISM; MOUSE MUTANT; NEOPLASM; PHYSIOLOGY;

ANIMALIA; MAMMALIA; RODENTIA;

ANIMALS; CELL AGING; CELL TRANSFORMATION, NEOPLASTIC; DNA-BINDING PROTEINS; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; NEOPLASMS; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; TELOMERASE;

EID: 0036856474     PISSN: 02678357     EISSN: None     Source Type: Journal    
DOI: 10.1093/mutage/17.6.539     Document Type: Review

References (117)

1. Aisner, D.L., Wright, W.E. and Shay, J.W. (2002) Telomerase regulation: not just flipping the switch. Curr. Opin. Genet. Dev., 12, 80-85.
2. Artandi, S.E., Alson, S., Tietze, M.K. et al. (2002) Constitutive telomerase expression promotes mammary carcinomas in aging mice. Proc. Natl Acad. Sci. USA, 28, 28.
3. Backsch, C., Wagenbach, N., Nonn, M., Leistritz, S., Stanbridge, E., Schneider, A. and Durst, M. (2001) Microcell-mediated transfer of chromosome 4 into HeLa cells suppresses telomerase activity. Genes Chromosomes Cancer, 31, 196-198.
4. Baur, J.A., Zou, Y., Shay, J.W. and Wright, W.E. (2001) Telomere position effect in human cells. Science, 292, 2075-2077.
5. Bechter, O.E., Eisterer, W., Dlaska, M., Kuhr, T. and Thaler, J. (2002) CpG island methylation of the hTERT promoter is associated with lower telomerase activity in B-cell lymphocytic leukemia. Exp. Hematol., 30, 26-33.
6. Belinksy, S.A., Nikula, K.J., Palmisano, W.A., Michels, R., Saccomanno, G., Gabrielson, E., Baylin, S.B. and Herman, J.G. (1998) Aberrant methylation of p16INK4A is an early event in lung cancer and a potential biomarker for early diagnosis. Proc. Natl Acad. Sci. USA, 95, 11891-11896.
7. Bennett, D.C. and Medrano, E.E. (2002) Molecular regulation of melanocyte senescence. Pigment Cell Res., 15, 242-250.
8. Blasco, M.A., Lee, H.W., Hande, M.P., Samper, E., Lansdorp, P.M., DePinho, R.A. and Greider, C.W. (1997) Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell, 91, 25-34.
9. Bodnar, A.G., Ouellette, M., Frolkis, M., Holt, S.E., Chiu, C.P., Morin, G.B., Harley, C.B., Shay, J.W., Lichtsteiner, S. and Wright, W.E. (1998) Extension of life-span by introduction of telomerase into normal human cells. Science, 279, 349-352.
10. Brenner, A.J., Stampfer, M.R. and Aldaz, C.M. (1998) Increased p16 expression with first senescence arrest in human mammary epithelial cells and extended growth capacity with p16 inactivation. Oncogene, 17, 199-205.
11. Bryan, T.M., Englezou, A., Gupta, J., Bacchetti, S. and Reddel, R.R. (1995) Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J., 14, 4240-4248.
12. Bryan, T.M., Englezou, A., Dalla-Pozza, L., Dunham, M.A. and Reddel, R.R. (1997) Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nature Med., 3, 1271-1274.
13. Bryce, L.A., Morrison, N., Hoare, S.F., Muir S. and Keith, W.N. (2000) Mapping of the gene for the human reverse transcriptase, hTERT, to chromosome 5p15.33 by fluorescence in situ hybridization. Neoplasia, 2, 197-201.
14. Carman, T.A., Afshari, C.A. and Barrett, J.C. (1998) Cellular senescence in telomerase-expressing Syrian hamster embryo cells. Exp. Cell Res., 244, 33-42.
15. Carnero, A., Hudson, J.D., Price, C.M. and Beach, D.H. (2000) p16INK4A and p19ARF act in overlapping pathways in cellular immortalization. Nature Cell Biol., 2, 148-155.
16. Chang, S., Khoo, C. and DePinho, R.A. (2001) Modeling chromosomal instability and epithelial carcinogenesis in the telomerase-deficient mouse. Semin. Cancer Biol., 11, 227-239.
17. Chin, L., Artandi, S.E., Shen, Q., Tam, A., Lee, S.L,, Gottlieb, G.J., Greider, C.W. and DePinho, R.A. (1999) p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell, 97, 527-538.
18. Cong, Y.S., Wen, J. and Bacchetti, S. (1999) The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter. Hum. Mol. Genet., 8, 137-142.
19. Counter, C.M., Botelho, F.M., Wang, P., Harley, C.B. and Bacchetti, S. (1994a) Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. J. Virol., 68, 3410-3414.
20. Counter, C.M., Hirte, H.W., Bacchetti, S. and Harley, C.B. (1994b) Telomerase activity in human ovarian carcinoma. Proc. Natl Acad. Sci. USA, 91, 2900-2904.
21. Counter, C.M., Hahn, W.C., Wei, W., Caddle, S.D., Beijersbergen, R.L., Lansdorp, P.M., Sedivy, J.M. and Weinberg, R.A. (1998a) Dissociation among in vitro telomerase activity, telomere maintenance and cellular immortalization. Proc. Natl Acad. Sci. USA, 95, 14723-14728.
22. Counter, C.M., Meyerson, M., Eaton, E.N., Ellisen, L.W., Caddle, S.D., Haber, D.A. and Weinberg, R.A. (1998b) Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase. Oncogene, 16, 1217-1222.
23. Cuthbert, A.P., Bond, J., Trott, D.A., Gill, S., Broni, J., Marriott, A., Khoudoli, G., Parkinson, E.K., Cooper, C.S. and Newbold, R.F. (1999) Telomerase repressor sequences on chromosome 3 and induction of permanent growth arrest in human breast cancer cells. J. Natl Cancer Inst., 91, 37-45.
24. Damm, K., Hemmann, U., Garin-Chesa, P. et al. (2001) A highly selective telomerase inhibitor limiting human cancer cell proliferation. EMBO J., 20, 6958-6968.
25. Dickson, M.A., Hahn, W.C., Ino, Y., Ronfard, V, Wu, J.Y., Weinberg, R.A., Louis, D.N., Li, F.P. and Rheinwald, J.G. (2000) Human keratinocytes that express hTERT and also bypass a p16 (INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol. Cell. Biol., 20, 1436-1447.
26. Drayton, S. and Peters, G. (2002) Immortalization and transformation revisited. Current Opinion in Genetics and Dev., 12, 98-104.
27. Ducrest, A.L., Amacker, M., Mathieu, Y.D., Cuthbert, A.P., Trott, D.A., Newbold, R.F., Nabholz, M. and Lingner J. (2001) Regulation of human telomerase activity: repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity. Cancer Res., 61, 7594-7602.
28. Ducrest, A.L., Szutorisz, H., Lingner J. and Nabholz, M. (2002) Regulation of the human telomerase reverse transcriptase gene. Oncogene, 21, 541-552.
29. Elenbaas, B., Spirio, L., Koerner, F., Fleming, M.D., Zimonjic, D.B., Donaher, J.L., Popescu, N.C., Hahn, W.C. and Weinberg, R.A. (2001) Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev., 15, 50-65.
30. Espejel, S. and Blasco, M.A. (2002) Identification of telomere-dependent 'senescense-like' arrest in mouse embryonic fibroblasts. Exp. Cell. Res. 276, 242-248.
31. Espejel, S., Franco, S., Rodriguez-Perales, S., Bouffler, S.D., Cigudosa, J.C. and Blasco, M.A. (2002) Mammalian Ku86 mediates chromosomal fusions and apoptosis caused by critically short telomeres. EMBO J., 21, 2207-2219.
32. Feng, J., Funk, W.D., Wang, S.S. et al. (1995) The RNA component of human telomerase. Science, 269, 1236-1241.
33. Forsyth, N.R., Wright, W.E. and Shay, J.W. (2002) Telomerase and differentiation in multicellular organisms: turn it off, turn it on and turn it off again. Differentiation, 69, 188-197.
34. Foster, S.A., Wong, D.J., Barrett, M.T. and Galloway, D.A. (1998) Inactivation of p16 in human mammary epithelial cells by CpG island methylation. Mol. Cell. Biol., 18, 1793-1801.
35. Gonzalez-Suarez, E., Samper, E., Ramirez, A., Flores, J.M., Martin-Caballero, J., Jorcano, J.L. and Blasco, M.A. (2001) Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes. EMBO J., 20, 2619-2630.
36. Gowan, S.M., Heald, R., Stevens, M.F. and Kelland, L.R. (2001) Potent inhibition of telomerase by small-molecule pentacyclic acridines capable of interacting with G-quadruplexes. Mol. Pharmacol., 60, 981-988.
37. Greaves, M. (1996) Is telomerase activity in cancer due to selection of stem cells and differentiation arrest? Trends Genet., 12, 127-128.
38. Greenberg, R.A., Allsopp, R.C., Chin, L., Morin, G.B. and DePinho, R.A. (1998) Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation. Oncogene, 16, 1723-1730.
39. Greenberg, R.A., Chin, L., Femino, A., Lee, K.H., Gottlieb, G.J., Singer, R.H., Greider, C.W. and DePinho, R.A. (1999) Short dysfunctional telomeres impair tumorigenesis in the INK4a (delta2/3) cancer-prone mouse. Cell, 97, 515-525.
40. Greider, C.W. (1990) Telomeres, telomerase and senescence. Bioessays, 12, 363-369.
41. Greider, C.W. and Blackburn, E.H. (1985) Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell, 43, 405-413.
42. Greider, C.W. and Blackburn, E.H. (1987) The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity. Cell, 51, 887-898.
43. Griffith, J.D., Comeau, L., Rosenfield, S., Stansel, R.M., Bianchi, A., Moss, H. and de Lange, T. (1999) Mammalian telomeres end in a large duplex loop. Cell, 97, 503-514.
44. Hahn, W.C., Counter, C.M., Lundberg, A.S., Beijersbergen, R.L., Brooks, M.W. and Weinberg, R.A. (1999a) Creation of human tumour cells with defined genetic elements. Nature, 400, 464-468.
45. Hahn, W.C., Stewart, S.A., Brooks, M.W., York, S.G., Eaton, E., Kurachi, A., Beijersbergen, R.L., Knoll, J.H., Meyerson, M. and Weinberg, R.A. (1999b) Inhibition of telomerase limits the growth of human cancer cells. Nature Med., 5, 1164-1170.
46. Hahn, W.C., Dessain, S.K., Brooks, M.W., King, J.E., Elenbaas, B., Sabatini, D.M., DeCaprio, J.A. and Weinberg, R.A. (2002) Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol. Cell. Biol., 22, 2111-2123.
47. Hande, M.P., Samper, E., Lansdorp, P. and Blasco, M.A. (1999) Telomere length dynamics and chromosomal instability in cells derived from telomerase null mice. J. Cell Biol., 144, 589-601.
48. Harley, C.B. (1991) Telomere loss: mitotic clock or genetic time bomb? Mutat. Res., 256, 271-282.
49. Harley, C.B., Futcher, A.B. and Greider, C.W. (1990) Telomeres shorten during ageing of human fibroblasts. Nature, 345, 458-460.
50. Hayflick, L. (1965) The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res., 37, 614-636.
51. Hayflick, L. and Moorhead, P.S. (1961) The serial cultivation of human diploid cell strains. Esp. Cell Res., 25, 585-621.
52. Hemann, M.T., Strong, M.A., Hao, L.Y. and Greider, C.W. (2001) The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell, 107, 67-77.
53. Henson, J.D., Neumann, A.A., Yeager, T.R. and Reddel, R.R. (2002) Alternative lengthening of telomeres in mammalian cells. Oncogene, 21, 598-610.
54. Herbert, B., Pitts, A.E., Baker, S.I., Hamilton, S.E., Wright, W.E., Shay, J.W. and Corey, D.R. (1999) Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death. Proc. Natl Acad. Sci. USA, 96, 14276-14281.
55. Herman, J.G., Merlo, A., Mao, L., Lapidus, R.G., Issa, J.P., Davidson, N.E., Sidransky, D. and Baylin, S.B. (1995) Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res., 55, 4525-4530.
56. Herrera, E., Samper, E., Martin-Caballero, J., Flores, J.M., Lee, H.W. and Blasco, M.A. (1999) Disease states associated with telomerase deficiency appear earlier in mice with short telomeres. EMBO J., 18, 2950-2960.
57. Hou, M., Wang, X., Popov, N. et al. (2002) The histone deacetylase inhibitor trichostatin A derepresses the telomerase reverse transcriptase (hTERT) gene in human cells. Exp. Cell Res., 274, 25-34.
58. INK4 expression by methylation is associated with life span extension of human mammary epithelial cells. Cancer Res., 58, 3508-3512.
59. Jiang, X.R., Jimenez, G., Chang, E. et al. (1999) Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nature Genet., 21, 111-114.
60. Kelland, L.R. (2001) Telomerase: biology and phase I trials. Lancet Oncol., 2, 95-102.
61. Kim, N.W., Piatyszek, M.A., Prowse, K.R., Harley, C.B., West, M.D., Ho, PL., Coviello, G.M., Wright, W.E., Weinrich, S.L. and Shay, J.W. (1994) Specific association of human telomerase activity with immortal cells and cancer. Science, 266, 2011-2015.
62. Kiyono, T., Foster, S.A., Koop, J.I., McDougall, J.K., Galloway, D.A. and Klingelhutz, A.J. (1998) Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature, 396, 84-88.
63. Kyo, S., Takakura, M., Taira, T., Kanaya, T., Itoh, H., Yutsudo, M., Ariga, H. and Inoue, M. (2000) Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT). Nucleic Acids Res., 28, 669-677.
64. Land, H., Parada, L.F. and Weinberg, R.A. (1983) Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature, 304, 596-602.
65. Lee, H.W., Blasco, M.A., Gottlieb, G.J., Horner, J.W., Greider, C.W. and DePinho, R.A. (1998) Essential role of mouse telomerase in highly proliferative organs. Nature, 392, 569-574.
66. Loo, D.T., Fuquay, J.I., Rawson, C.L. and Barnes, D.W. (1987) Extended culture of mouse embryo cells without senescence: inhibition by serum. Science, 236, 200-202.
67. Lundblad, V. and Blackburn, E.H. (1993) An alternative pathway for yeast telomere maintenance rescues est1- senescence. Cell, 73, 347-360.
68. Lundblad, V. and Szostak, J.W. (1989) A mutant with a defect in telomere elongation leads to senescence in yeast. Cell, 57, 633-643.
69. McEachern, M.J. and Blackburn, E.H. (1996) Cap-prevented recombination between terminal telomeric repeat arrays (telomere CPR) maintains telomeres in Kluyveromyces lactis lacking telomerase. Genes Dev., 10, 1822-1834.
70. Meyerson, M., Counter, C.M., Eaton, E.N. et al. (1997) hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell, 90, 785-795.
71. Morales, C.P, Holt, S.E., Ouellette, M., Kaur, K.J., Yan, Y., Wilson, K.S., White, M.A., Wright, W.E. and Shay, J.W. (1999) Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nature Genet., 21, 115-118.
72. Morin, G.B. (1989) The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell, 59, 521-529.
73. Munro, J., Stott, F.J., Vousden, K.H., Peters, G. and Parkinson, E.K. (1999) Role of the alternative INK4A proteins in human keratinocyte senescence: evidence for the specific inactivation of p16INK4A upon immortalization. Cancer Res., 59, 2516-2521.
74. Nakabayashi, K., Ogino, H., Michishita, E., Satoh, N. and Ayusawa, D. (1999) Introduction of chromosome 7 suppresses telomerase with shortening of telomeres in a human mesothelial cell line. Exp. Cell Res., 252, 376-382.
75. Newbold, R.F. (1985a) Malignant transformation of mammalian cells in culture: delineation of stages and role of cellular oncogene activation. IARC Sci. Publ., 67, 31-53.
76. Newbold, R.F. (1985b) Multistep malignant transformation of mammalian cells by carcinogens: induction of immortality as a key event. Carcinog. Compr. Surv., 9, 17-28.
77. Newbold, R.F. (1997) Genetic control of telomerase and replicative senescence in human and rodent cells. Ciba Found. Symp., 211, 177-189.
78. Newbold, R.F. and Overell, R.W. (1983) Fibroblast immortality is a prerequisite for transformation by EJ c-Ha-ras oncogene. Nature, 304, 648-651.
79. Newbold, R.F., Overell, R.W. and Connell, J.R. (1982) Induction of immortality is an early event in malignant transformation of mammalian cells by carcinogens. Nature, 299, 633-635.
80. Nishimoto, A., Miura, N., Horikawa, I. et al. (2001) Functional evidence for a telomerase repressor gene on human chromosome 10p15.1. Oncogene, 20, 828-835.
81. Ohmura, H., Tahara, H., Suzuki, M., Ide, T., Shimizu, M., Yoshida, M.A., Tahara, E., Shay, J.W., Barrett, J.C. and Oshimura, M. (1995) Restoration of the cellular senescence program and repression of telomerase by human chromosome 3. Jpn. J. Cancer Res., 86, 899-904.
82. Olovnikov, A.M. (1973) A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J. Theor. Biol., 41, 181-190.
83. Ozer, H.L. (2000) SV40-mediated immortalization. In Macieira-Coelho, A. (ed.), Cell Immortalization. Springer, Berlin, Germany, pp. 121-154.
84. Parkinson, E.K., Munro, J., Steeghs, K., Morrison, V., Ireland, H., Forsyth, N., Fitzsimmons, S. and Bryce, S. (2000) Replicative senescence as a barrier to human cancer. Biochem. Soc. Trans., 28, 226-233.
85. Parkinson, G.N., Lee, M.P. and Neidle, S. (2002) Crystal structure of parallel quadruplexes from human telomeric DNA. Nature, 417, 876-880.
86. Pascolo, E., Wenz, C., Lingner, J., Hauel, N., Priepke, H., Kauffmann, I., Garin-Chesa, P., Rettig, W.J., Damm, K. and Schnapp, A. (2002) Mechanism of human telomerase inhibition by BIBR1532, a synthetic, non-nucleosidic drug candidate. J. Biol. Chem., 277, 15566-15572.
87. Perrem, K.T. (2001) Molecular studies of an alternative lengthening of telomeres (ALT) mechanism. PhD thesis, University of Sydney.
88. Perrem, K., Bryan, T.M., Englezou, A., Hackl, T., Moy, E.L. and Reddel, R.R. (1999) Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybrids. Oncogene, 18, 3383-3390.
89. Pierce, G.B. (1977) Relationship between differentiation and carcinogenesis. J. Toxicol. Environ. Health, 2, 1335-1342.
90. Quelle, D.E., Zindy, F., Ashmun, R.A. and Sherr, C.J. (1995) Alternative reading frames of the INK4A tumour suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell, 83, 993-1000.
91. Ramirez, R.D., Morales, C.P., Herbert, B.S., Rohde, J.M., Passons, C., Shay, J.W. and Wright, W.E. (2001) Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions. Genes Dev., 15, 398-403.
92. Reddel, R.R. (2000) The role of senescence and immortalization in carcinogenesis. Carcinogenesis, 21, 477-484.
93. Riou, J.F., Guittat, L., Mailliet, P., Laoui, A., Renou, E., Petitgenet, O., Megnin-Chanet, F., Helene, C. and Mergny, J.L. (2002) Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands. Proc. Natl Acad. Sci. USA, 99, 2672-2677.
94. Romanov, S.R., Kozakiewicz, B.K., Holst, C.R., Stampfer, M.R., Haupt, L.M. and Tlsty, T.D. (2001) Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes. Nature, 409, 633-637.
95. Rudolph, K.L., Chang, S., Lee, H.W., Blasco, M., Gottlieb, G.J., Greider, C. and DePinho, R.A. (1999) Longevity, stress response and cancer in aging telomerase-deficient mice. Cell, 96, 701-712.
96. Ruley, H.E. (1983) Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture. Nature, 304, 602-606.
97. Russo, I., Silver, A.R., Cuthbert, A.P., Griffin, D.K., Trott, D.A. and Newbold, R.F. (1998) A telomere-independent senescence mechanism is the sole barrier to Syrian hamster cell immortalization. Oncogene, 17, 3417-3426.
98. Serrano, M., Hannon, G.J. and Beach, D. (1993) A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature, 366, 704-707.
99. INK4a. Cell, 88, 593-602.
100. Sharpless, N.E., Bardeesy, N., Lee, K.H., Carrasco, D., Castrillon, D.H., Aguirre, A.J., Wu, E.A., Homer, J.W. and DePinho, R.A. (2001) Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis. Nature, 413, 86-91.
101. Shay, J.W. and Wright, W.E. (1996) The reactivation of telomerase activity in cancer progression. Trends Genet., 12, 129-131.
102. Steenbergen, R.D., Kramer, D., Meijer, C.J., Walboomers, J.M., Trott, D.A., Cuthbert, A.P., Newbold, R.F, Overkamp, W.J., Zdzienicka, M.Z. and Snijders, P.J. (2001) Telomerase suppression by chromosome 6 in a human papillomavirus type 16-immortalized keratinocyte cell line and in a cervical cancer cell line. J. Natl Cancer Inst., 93, 865-872.
103. Steinert, S., White, D.M., Zou, Y., Shay, J.W. and Wright, W.E. (2002) Telomere biology and cellular aging in nonhuman primate cells. Exp. Cell Res., 272, 146-152.
104. Takakura, M., Kyo, S., Sowa, Y., Wang, Z., Yatabe, N., Maida, Y., Tanaka, M. and Inoue, M. (2001) Telomerase activation by histone deacetylase inhibitor in normal cells. Nucleic Acids Res., 29, 3006-3011.
105. Tang, D.G., Tokumoto, Y.M., Apperly, J.A., Lloyd, A.C. and Raff, M.C. (2001) Lack of replicative senescence in cultured rat oligodendrocyte precursor cells. Science, 291, 868-871.
106. Teng, S.C. and Zakian, V.A. (1999) Telomere-telomere recombination is an efficient bypass pathway for telomere maintenance in Saccharomyces cerevisiae. Mol. Cell. Biol., 19, 8083-8093.
107. Trott, D.A., Cuthbert, A.P., Overell, R.W., Russo, I. and Newbold, R.F. (1995) Mechanisms involved in the immortalization of mammalian cells by ionizing radiation and chemical carcinogens. Carcinogenesis, 16, 193-204.
108. Vonderheide, R.H. (2002) Telomerase as a universal tumor-associated antigen for cancer immunotherapy. Oncogene, 21, 674-679.
109. Webley, K., Bond, J.A., Jones, C.J., Blaydes, J.P., Craig, A., Hupp, T. and Wynford-Thomas, D. (2000) Posttranslational modifications of p53 in replicative senescence overlapping but distinct from those induced by DNA damage. Mol. Cell. Biol, 20, 2803-2808.
110. White, L.K., Wright, W.E. and Shay, J.W. (2001) Telomerase inhibitors. Trends Biotechnol., 19, 114-120.
111. Wick, M., Zubov, D. and Hagen, G. (1999) Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT). Gene, 232, 97-106.
112. Wright, W.E. and Shay, J.W. (2001) Cellular senescence as a tumor-protection mechanism: the essential role of counting. Curr. Opin. Genet. Dev., 11, 98-103.
113. Wright, W.E., Pereira-Smith, O.M. and Shay, J.W. (1989) Reversible cellular senescence: implications for immortalization of normal human diploid fibroblasts. Mol. Cell. Biol., 9, 3088-3092.
114. Wynford-Thomas, D. (1999) Cellular senescence and cancer. J. Pathol., 187, 100-111.
115. Xu, D., Popov, N., Hou, M., Wang, Q., Bjorkholm, M., Gruber, A., Menkel, A.R. and Henriksson, M. (2001) Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells. Proc. Natl Acad. Sci. USA, 98, 3826-3831.
116. Yaswen, P. and Stampfer, M.R. (2002) Molecular changes accompanying senescence and immortalization of cultured human mammary epithelial cells. Int. J. Biochem. Cell Biol., 1300, 1-13.
117. Zhang, X., Mar, V., Zhou, W., Harrington, L. and Robinson, M.O. (1999) Telomere shortening and apoptosis in telomerase-inhibited human tumour cells. Genes Dev., 13, 2388-2399.